Ahmed Sami

Experience

• 

  Takeda

  Jan 2010 - Sept 2018

  • Commercial & Market Access Manager, Gulf & Lebanon

    Mar 2017 - Sept 2018

  • District Sales Manager, Dubai & NA

    Sept 2015 - Feb 2017

  • Medical Representative

    Sept 2012 - Aug 2015

  • Medical Representative

    Jan 2010 - Aug 2012
• 

  NOVIMED

  Oct 2018 - Jul 2021

  Co-Founder
• 

  Insulet International

  Jan 2022 - now

  Head of Market Access, Middle East

  As Head of Market Access for the Middle East, I drive strategies that enhance patient access, secure reimbursement, and shape policy frameworks for innovative diabetes technology. My role covers tender management, pricing strategy, governmental partnerships, and health technology assessment (HTA) to ensure sustainable market growth.Key Achievements:✅ Tenders Submission & ManagementLed the end-to-end process for tenders, ensuring strong market positioning and compliance with procurement requirements.✅ Policy Development for Diabetes Technology AccessEngaged with payers and policymakers to advocate for favorable regulatory policies, improving patient access to insulin delivery systems.✅ Patient Access Programs (UAE & Turkey)Launched patient access programs, increasing affordability and adoption by collaborating with health authorities and stakeholders.✅ Pricing Strategy & Market AnalysisDeveloped an in-market pricing strategy, optimizing competitiveness while aligning with payer expectations.✅ Governmental Partnerships in UAEBuilt strategic collaborations with UAE health authorities, fostering public-private partnerships to expand market access.✅ Reimbursement & HTA ApprovalsSuccessfully secured reimbursement and HTA assessments, demonstrating clinical and economic value for Insulet’s technology.✅ Market Modeling & Strategic PlanningDesigned data-driven market models to forecast trends, optimize pricing, and support expansion strategies.Through these initiatives, I have strengthened regional market access, payer relationships, and policy engagement, ensuring broader adoption of innovative diabetes solutions. Show less